An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia. - Wikidata - awgldk - TriplyDB

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.

http://www.wikidata.org/entity/Q37641297

about

Fructose Intake, Serum Uric Acid, and Cardiometabolic Disorders: A Critical Review.A Novel Multi-Epitope Vaccine Based on Urate Transporter 1 Alleviates Streptozotocin-Induced Diabetes by Producing Anti-URAT1 Antibody and an Immunomodulatory Effect in C57BL/6J Mice.Allopurinol and risk of benign prostatic hyperplasia in a Finnish population-based cohort.Effects of Allopurinol on Endothelial Function: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Trials.ABCG2 as a therapeutic target candidate for gout.The Effect of Xanthine Oxidase Inhibitors on Blood Pressure and Renal Function.Physiology of Hyperuricemia and Urate-Lowering Treatments.

P2860

Q30234756-CE453D7D-3A66-41B8-9C7A-BF484710D976 Q47141516-5510D713-62D3-4088-9ECC-9B62AE0D6550 Q47570403-D0C36B61-B115-4536-8BC7-A4B99A3694EA Q47594590-92648C29-C2E3-49BD-A656-A66F99E9AAD1 Q47770438-BE03904B-505D-4242-A37E-18AD8C431250 Q50086018-2135F586-2FB6-4D4D-82FA-035AF8BCF417 Q55163806-B02F56DF-4277-4E6A-856C-6E0B82A87780

P2860

An evidence-based review on urate-lowering treatments: implications for optimal treatment of chronic hyperuricemia.

http://www.wikidata.org/entity/Q37641297

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 February 2017

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@en

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@nl

type

label

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@en

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@nl

prefLabel

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@en

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@nl

P1433

Q37641297-3080BC70-4533-4658-9F06-6FAD43BFDCD6

P1476

Q37641297-FD5E422D-51B9-4A6C-8942-9718D12C5F9E

P2093

Q37641297-065CB141-3B3A-4B34-B51D-80D646B0136E

Q37641297-304955F1-FF30-45CB-A6E0-115AB84373A1

Q37641297-501D5473-4C21-45E7-AC96-16553EF529C2

Q37641297-D3D08F7F-7767-4ABD-8B6E-3FC85A72C6F2

P275

Q37641297-FC00C849-1159-40E6-8F98-CF2BB1E94BED

P2860

Q37641297-1206EA95-0072-4B4F-AE91-9A6F50B710CC

Q37641297-154F01D6-6472-4D5C-8C4E-92760A4A43C7

Q37641297-1FD1DC4C-E0D5-41CB-8995-9B739C7ABFC7

Q37641297-27DF3B44-E086-4636-B2F6-EC6998EC4854

Q37641297-29F2E297-C0EC-4CA0-8C22-8490192DD16F

Q37641297-2D121605-8C47-49CE-991A-7CF7FAAFDDFB

Q37641297-2EE242FD-984D-4FB4-AE0D-838EB4DF7469

Q37641297-335EBBD7-BB94-4AA6-8B74-F034DABFAAD2

Q37641297-39D0D103-B184-44D7-995E-9E2FBE918163

Q37641297-4589C750-93C1-4FBD-9382-8380F10A43F6

P304

Q37641297-A86873B1-66CF-4A6B-B64A-59CA1819592B

P31

Q37641297-0BF3EAEA-1E31-4007-874F-3EEDE007B407

Q37641297-2B1FD75E-DFF4-4D66-AE8B-60A696F4B5E4

P356

Q37641297-A8182253-A0F0-48EC-BBEA-687C640D53C8

P407

Q37641297-5019D39D-CAC5-4FE3-B32F-05DF9690355A

P478

Q37641297-44264D3A-3DDC-45A1-9FE7-78C7A49DD3F1

P5008

Q37641297-16876E49-1342-4771-BDB4-8A6804DAA234

P577

Q37641297-CE40FB76-46BF-478A-95C4-857BAFAF2076

P698

Q37641297-AB1E04ED-7A1E-449E-B94E-B7ED4A95CF4E

P921

Q37641297-50F253DB-FC9B-4FD4-81D2-66559A4B6CDE

Q37641297-58008272-80D8-42E0-8451-65DDD634F5DB

Q37641297-6A0ACD69-ECCC-40EE-8317-C0DE281082C8

P932

Q37641297-12EC5907-8FA0-40A7-97C1-BE37AE79F0A9

P356

P1433

Vascular Health and Risk Management

P1476

An evidence-based review on ur ...... ment of chronic hyperuricemia.

@en

P2093

Arrigo Francesco Giuseppe Cicero

http://www.w3.org/2001/XMLSchema#string

Claudio Borghi

http://www.w3.org/2001/XMLSchema#string

Maddalena Veronesi

http://www.w3.org/2001/XMLSchema#string

Marilisa Bove

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Effect of allopurinol in chronic kidney disease progression and cardiovascular risk

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

Urate lowering therapies in the treatment of gout: a systematic review and meta-analysis

2016 updated EULAR evidence-based recommendations for the management of gout.

Structure and function of xanthine oxidoreductase: where are we now?

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Rising burden of gout in the UK but continuing suboptimal management: a nationwide population study

Physiological roles of xanthine oxidoreductase.

P304

23-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/VHRM.S115080

http://www.w3.org/2001/XMLSchema#string

P407

P478

13

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2017-02-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28223818

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

5308472

http://www.w3.org/2001/XMLSchema#string